Prévisions du marché européen de la thérapie contre l\'arthrose jusqu\'en 2030 – Analyse régionale – par type de thérapie (stimulation nerveuse électrique transcutanée (TENS), ergothérapie, physiothérapie, thérapie par plasma riche en plaquettes et fraction vasculaire stromale, prolothérapie et autres), indication de la maladie (arthrose du genou , arthrose de la colonne vertébrale, arthrose du pied et de la cheville, arthrose de l\'épaule, arthrose de la main et autres) et utilisateur final (hôpitaux et cliniques, cliniques spécialisées, centres de chirurgie ambulatoire, soins à domicile et autres)

BMIRE00030422 | Pages: 108 | Medical Device | Jul 2024 | Type: Regional | Status: Published
Le marché européen du traitement de l\'arthrose était évalué à 4 971,51 millions de dollars US en 2022 et devrait atteindre 8 743,93 millions de dollars US d\'ici 2030 ; on estime qu\'il enregistrera un TCAC de 7,3 % de 2022 à 2030.

La disponibilité de la médecine régénérative stimule le marché européen de la thérapie contre l\'arthrose

La médecine régénérative est une alternative nouvelle et potentiellement transformatrice aux options thérapeutiques traditionnelles pour traiter l\'arthrose. La médecine régénérative utilise l\'ingénierie biomédicale, les biomatériaux et les thérapies cellulaires qui ciblent le système immunitaire de l\'organisme pour traiter l\'arthrose. En outre, les chercheurs cliniques ont développé des méthodes pour fixer le cartilage articulaire des patients à l\'aide de cellules (autologues) de patients. De plus, les options de thérapie régénérative utilisent « l’implantation de chondrocytes autologues induite par une matrice (MACI) ». MACI peut réparer de petites zones de cartilage, empêchant ou retardant l\'arthrose. Aussi, plusieurs fabricants développent des produits axés sur la thérapie régénérative. L’inclination croissante vers des approches non chirurgicales telles que la thérapie PRP, la thérapie par cellules souches, les injections d’acide hyaluronique et la prolothérapie propulserait l’adoption de la médecine régénérative. Les patients souffrant d\'arthrose peuvent être traités à l\'aide de thérapies non pharmacologiques. Les options de thérapie régénérative peuvent améliorer les fonctions articulaires en réduisant la douleur et en améliorant la qualité de vie globale des personnes souffrant d\'arthrose. Par conséquent, l’adoption croissante de la médecine régénérative devrait ouvrir de nouvelles opportunités commerciales sur le marché du traitement de l’arthrose au cours de la période de prévision.

Aperçu du marché européen du traitement de l\'arthrose

Le marché européen du traitement de l\'arthrose est segmenté en Allemagne, au Royaume-Uni, en France, en Italie, en Espagne et dans le reste de l\'Europe. Les approbations rapides de produits dans la région pour les médicaments destinés au traitement de l’arthrose et les infrastructures de soins de santé avancées sont les facteurs les plus influents responsables de la croissance du marché. Selon le rapport du Journal of Health Monitoring, l\'arthrose est la maladie articulaire la plus courante en Allemagne. Les douleurs articulaires et la perte de fonction sont susceptibles d\'entraîner une perte de qualité de vie, car l\'arthrose est provoquée dans les membres supérieurs (doigts, mains et épaules). Par conséquent, avec le vieillissement de la population allemande, la prévalence de l\'arthrose va continuer à augmenter, ce qui entraînera une lourde charge pour le système de santé. Selon le rapport de l’Organisation mondiale de la santé (OMS) publié en 2020, les décès dus à l’arthrose en Allemagne représentent 0,05 % du total des décès. De plus, les lancements de nouveaux produits renforcent la croissance du marché. Par exemple, en mai 2023, Grünenthal a annoncé avoir reçu l\'approbation d\'un médicament expérimental non opioïde « Résinifératoxine (RTX) », actuellement en cours de développement clinique de phase 3, qui constitue une thérapie révolutionnaire par la Food and Drug Administration (USFDA) des États-Unis pour traiter l\'arthrose du genou. La résinifératoxine peut devenir une option thérapeutique non opioïde significative, procurant un soulagement durable de la douleur et une amélioration fonctionnelle de l’articulation affectée.

Revenus et prévisions du marché européen du traitement de l\'arthrose jusqu\'en 2030 (millions de dollars américains)

Segmentation du marché européen du traitement de l\'arthrose

Le marché européen du traitement de l\'arthrose est classé en type de thérapie et en indications de maladie. , l\'utilisateur final et le pays.

En fonction du type de thérapie, le marché européen du traitement de l\'arthrose est segmenté en stimulation nerveuse électrique transcutanée (TENS), ergothérapie, physiothérapie, thérapie par plasma riche en plaquettes (PRP) et fraction vasculaire stromale, prolothérapie et autres. . Le segment de la physiothérapie détenait la plus grande part de marché en 2022.

En termes d\'indications de maladies, le marché européen du traitement de l\'arthrose est segmenté en arthrose du genou, arthrose de la colonne vertébrale, arthrose du pied et de la cheville, arthrose de l\'épaule, arthrose de la main et autres. Le segment de l\'arthrose du genou détenait la plus grande part du marché européen du traitement de l\'arthrose en 2022.

Sur la base des utilisateurs finaux, le marché européen du traitement de l\'arthrose est classé en hôpitaux et cliniques, cliniques spécialisées, centres de chirurgie ambulatoire, soins à domicile et autres. . Le segment des soins à domicile détenait la plus grande part du marché européen du traitement de l\'arthrose en 2022.

Par pays, le marché européen du traitement de l\'arthrose est segmenté entre le Royaume-Uni, l\'Allemagne, la France, l\'Italie, l\'Espagne et le reste de l\'Europe. L\'Allemagne a dominé la part de marché européenne du traitement de l\'arthrose en 2022.

Zimmer Biomet Holdings Inc, DePuy Synthes Inc, Bioventus Inc, Omron Healthcare Inc, Exactech Inc et Medi GmbH & Co KG font partie des principales sociétés opérant dans ce pays. le marché européen du traitement de l\'arthrose.

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Osteoarthritis Therapy Market Landscape

4.1 Pipeline Analysis

4.1.1 Clinical Trial Pipeline Analysis

5. Europe Osteoarthritis Therapy Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Prevalence of Osteoarthritis

5.1.2 Innovative Therapy Options Reducing Dependency on Medications

5.2 Market Restraints

5.2.1 Product Recall

5.3 Market Opportunities

5.3.1 Availability of Regenerative Medicine

5.4 Future Trends

5.4.1 More Effective Treatment Options

5.5 Impact of Drivers and Restraints:

6. Osteoarthritis Therapy Market - Europe Market Analysis

6.1 Overview

6.1.1 Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030

7. Europe Osteoarthritis Therapy Market Analysis - by Therapy Type

7.1 Overview

7.2 Transcutaneous Electrical Nerve Stimulation (TENS)

7.2.1 Overview

7.2.2 Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

7.3 Occupational Therapy

7.3.1 Overview

7.3.2 Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Physical Therapy

7.4.1 Overview

7.4.2 Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

7.5 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction

7.5.1 Overview

7.5.2 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

7.6 Prolotherapy

7.6.1 Overview

7.6.2 Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Osteoarthritis Therapy Market Analysis - by Disease Indication

8.1 Overview

8.2 Knee Osteoarthritis

8.2.1 Overview

8.2.2 Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8.3 Spine Osteoarthritis

8.3.1 Overview

8.3.2 Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Foot and Ankle Osteoarthritis

8.4.1 Overview

8.4.2 Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Shoulder Osteoarthritis

8.5.1 Overview

8.5.2 Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8.6 Hand Osteoarthritis

8.6.1 Overview

8.6.2 Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8.7 Others

8.7.1 Overview

8.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Osteoarthritis Therapy Market Analysis - by End User

9.1 Overview

9.2 Hospitals and Clinics

9.2.1 Overview

9.2.2 Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9.3 Specialty Clinics

9.3.1 Overview

9.3.2 Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9.4 Ambulatory Surgical Centers

9.4.1 Overview

9.4.2 Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9.5 Homecare

9.5.1 Overview

9.5.2 Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Osteoarthritis Therapy Market - Country Analysis

10.1 Europe Market Overview

10.1.1 Europe: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country

10.1.1.1 United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 Overview

10.1.1.1.2 United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.3 United Kingdom: Osteoarthritis Therapy Market Breakdown, by Therapy Type

10.1.1.1.4 United Kingdom: Osteoarthritis Therapy Market Breakdown, by Disease Indication

10.1.1.1.5 United Kingdom: Osteoarthritis Therapy Market Breakdown, by End User

10.1.1.2 Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Overview

10.1.1.2.2 Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.3 Germany: Osteoarthritis Therapy Market Breakdown, by Therapy Type

10.1.1.2.4 Germany: Osteoarthritis Therapy Market Breakdown, by Disease Indication

10.1.1.2.5 Germany: Osteoarthritis Therapy Market Breakdown, by End User

10.1.1.3 France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Overview

10.1.1.3.2 France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.3 France: Osteoarthritis Therapy Market Breakdown, by Therapy Type

10.1.1.3.4 France: Osteoarthritis Therapy Market Breakdown, by Disease Indication

10.1.1.3.5 France: Osteoarthritis Therapy Market Breakdown, by End User

10.1.1.4 Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.1 Overview

10.1.1.4.2 Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.3 Italy: Osteoarthritis Therapy Market Breakdown, by Therapy Type

10.1.1.4.4 Italy: Osteoarthritis Therapy Market Breakdown, by Disease Indication

10.1.1.4.5 Italy: Osteoarthritis Therapy Market Breakdown, by End User

10.1.1.5 Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.1 Overview

10.1.1.5.2 Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.3 Spain: Osteoarthritis Therapy Market Breakdown, by Therapy Type

10.1.1.5.4 Spain: Osteoarthritis Therapy Market Breakdown, by Disease Indication

10.1.1.5.5 Spain: Osteoarthritis Therapy Market Breakdown, by End User

10.1.1.6 Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.1 Overview

10.1.1.6.2 Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.3 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by Therapy Type

10.1.1.6.4 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by Disease Indication

10.1.1.6.5 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by End User

11. Industry Landscape

11.1 Overview

11.2 Growth Strategies in the osteoarthritis therapy market

11.3 Organic Developments

11.3.1 Overview

11.1 Inorganic Developments

11.1.1 Overview

12. Company Profiles

12.1 Zimmer Biomet Holdings Inc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 DePuy Synthes Inc

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Bioventus Inc

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Omron Healthcare Inc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Exactech Inc

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Medi GmbH & Co KG

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

13. Appendix

13.1 About the Insight Partners

List of Tables

Table 1. Osteoarthritis Therapy Market Segmentation

Table 2. Ongoing Clinical Trial of Osteoarthritis

Table 3. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type

Table 4. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication

Table 5. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 6. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type

Table 7. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication

Table 8. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 9. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type

Table 10. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication

Table 11. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 12. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type

Table 13. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication

Table 14. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 15. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type

Table 16. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication

Table 17. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 18. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type

Table 19. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication

Table 20. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 21. Organic Developments Done by Companies

Table 22. Inorganic Developments Done by Companies

List of Figures

Figure 1. Osteoarthritis Therapy Market Segmentation, by Country

Figure 2. Osteoarthritis Therapy Market - Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030

Figure 5. Osteoarthritis Therapy Market Share (%) - by Therapy Type (2022 and 2030)

Figure 6. Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Osteoarthritis Therapy Market Share (%) - by Disease Indication (2022 and 2030)

Figure 13. Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Osteoarthritis Therapy Market Share (%) - by End User (2022 and 2030)

Figure 20. Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 24. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 25. Europe: Osteoarthritis Therapy Market - Revenue by Key Countries Revenue 2022 (US$ Million)

Figure 26. Europe: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 27. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)

Figure 28. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)

Figure 29. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)

Figure 30. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)

Figure 31. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)

Figure 32. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)

Figure 33. Growth Strategies in the Osteoarthritis Therapy market

1. Zimmer Biomet Holdings Inc 
2. DePuy Synthes Inc 
3. Bioventus Inc 
4. Omron Healthcare Inc 
5. Exactech Inc 
6. Medi GmbH & Co KG 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe osteoarthritis therapy market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe osteoarthritis therapy market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe osteoarthritis therapy market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440